Watson CEO OK'd To Quiz FTC In Subpoena Dustup

Law360, New York (July 14, 2010, 7:25 PM EDT) -- Watson Pharmaceuticals Inc. CEO Paul M. Bisaro has won a bid to conduct discovery into whether the Federal Trade Commission shared confidential information with a rival of the generic-drug maker in an effort to force Bisaro to testify in a competition probe triggered by a patent case settlement over the narcolepsy treatment Provigil.

Such discovery is rarely granted, but Bisaro made a colorable claim that the FTC may have exceeded its authority by pressuring Watson to enter into a deal with rival Apotex Inc., according to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.